Nektar Therapeutics (NKTR) by event type
NKTR moves most on analyst upgrades — a median of -1.28% at 30 minutes across 15 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the NKTR overview →
How NKTR reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,651 of 2,717 | 15 | -1.28% | 27% | -0.33% |
| Coverage initiations 1,104 of 2,283 | 37 | 0.00% | 49% | -0.76% |
| Rating reiterations 958 of 3,522 | 45 | +0.08% | 56% | -0.49% |
| Price-target raises 1,304 of 1,790 | 15 | -0.09% | 47% | -0.30% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how NKTR usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · NKTR overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TROVAGENE (TROV) | 906 | -0.52% | 40% |
| KemPharm, Inc. (KMPH) | 901 | -0.21% | 40% |
| Tandem Diabetes Care, Inc. (TNDM) | 895 | +0.13% | 57% |
| Flexion Therapeutics, Inc. (FLXN) | 891 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.